The venture was found in Asia in South Korea. The main office of represented VC is situated in the Seoul.
Deals in the range of 5 - 10 millions dollars are the general things for fund. Comparing to the other companies, this Partners Investment performs on 21 percentage points less the average number of lead investments. The fund is generally included in 2-6 deals every year. The higher amount of exits for fund were in 2018. Considering the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. The average startup value when the investment from Partners Investment is 10-50 millions dollars. The top activity for fund was in 2016. Despite it in 2019 the fund had an activity.
Among the most successful fund investment fields, there are Business Development, Education. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Vedanta Biosciences, Bionetix, Moai Games For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea. The fund has no exact preference in some founders of portfolio startups. When startup sums 3 of the founder, the probability for it to get the investment is little.
Besides them, we counted 4 critical employees of this fund in our database.
The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Partners Investment, startups are often financed by Partners Venture Capital, Softbank Ventures Asia, Samsung Ventures. The meaningful sponsors for the fund in investment in the same round are Softbank Ventures Asia, Korea Investment Partners, Timewise Investment. In the next rounds fund is usually obtained by Samsung Ventures, Formation 8, Softbank Ventures Asia.
Related Funds
Fund Name | Location |
Arnoldo Mondadori Editore S.p.A | Italy, Lombardy, Milan |
Boulder Brands | Boulder, Colorado, United States |
Dianshi Equity Investment | China, Shanxi, Yuci |
Durable Capital Partners | Chevy Chase, Maryland, United States |
Magnum Technologies | - |
Nippon Electric Glass | Japan, Otsu, Shiga Prefecture |
Pinnacle Ventures | California, Menlo Park, United States |
Tianjin Boyi Chuangwei Touzi | China, Guangdong, Tianjin |
Vatera Healthcare Partners | New York, New York, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
AIGEN Sciences | 16 Oct 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
Storelink | $17M | 19 Aug 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Xpanner | $13M | 26 Jun 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Dalpha | $10M | 24 Apr 2024 | South Korea, Gangwon-do, South Korea | ||
Artblood | $5M | 09 Apr 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Surginex | $7M | 27 Mar 2024 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
Soft Berry | $4M | 21 Mar 2024 | Jeju, Cheju-do, South Korea | ||
Cytonus Therapeutics | $11M | 03 Nov 2023 | San Diego, California, United States | ||
Quad Miners | $13M | 29 Oct 2023 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea |
– Ring Therapeutics is a Cambridge, Mass.-based life sciences company.
– The company raised $117m in Series B funding.
– Backers included Invus, Altitude Life Science Ventures, Partners Investment, UPMC Enterprises, alongside Flagship Pioneering.
– The new investment will be used for the continued development and expansion of its novel vector Anellogy™ platform.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
AIGEN Sciences | 16 Oct 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | |||
Storelink | $17M | 19 Aug 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Xpanner | $13M | 26 Jun 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Dalpha | $10M | 24 Apr 2024 | South Korea, Gangwon-do, South Korea | ||
Artblood | $5M | 09 Apr 2024 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Surginex | $7M | 27 Mar 2024 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
Soft Berry | $4M | 21 Mar 2024 | Jeju, Cheju-do, South Korea | ||
Cytonus Therapeutics | $11M | 03 Nov 2023 | San Diego, California, United States | ||
Quad Miners | $13M | 29 Oct 2023 | Yeoksamdong, Seoul-t'ukpyolsi, South Korea |